Notably, prostate cancer is frequently characterized by CHD1 loss, which may explain why certain tumors are inherently permissive to VSV, while those with intact CHD1 or MAP3K7 exhibit resistance. This evidence concerns the gene CHD1 and Familial prostate cancer.